| November 29, 2011 • Volume 8 / Number 23 |
The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer.
- Featured Article: Researchers Uncover New Mechanism of Resistance to Melanoma Drug »
- Survey of Oncologists Suggests Lack of Progress in Cancer Pain Management »
- Trial Confirms Efficacy of HPV Vaccine, Shows Cross-Protection »
- Genetic Study Yields Clues to Neuroendocrine Prostate Cancer »
- A Conversation with Dr. Mason Bond on Improving the Treatment of Patients
with Ewing Sarcoma »
- Study Raises Concerns about Using Cancer Cell Lines to Test Drug Resistance »
- Unexpected Complications: Treating Cancer during Pregnancy »
- Interpreting Risk: Direct-to-Consumer Genetic Testing »
- Featured Clinical Trial: Novel Combination Chemotherapy for Localized Ewing Sarcoma »
Do you know someone who would enjoy receiving the NCI Cancer Bulletin? To send a copy of the latest issue to a colleague, visit www.cancer.gov/ncicancerbulletin. The NCI Cancer Bulletin will be sent to you biweekly unless you unsubscribe. To unsubscribe, send a blank email to nci-bulletin-signoff-request@list.nih.gov. |